The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The esophageal dysphagia market has experienced robust growth, reaching $1.96 billion in 2023. This upward trajectory is set to continue, with a projected increase to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. Looking ahead, the market is poised for even stronger growth, reaching $2.67 billion by 2028, fueled by a CAGR of 6.4%. The key drivers of this growth include factors such as the aging population, the prevalence of gastroesophageal reflux disease (GERD), advances in endoscopy, and esophageal motility testing.

Rising Smoking Rates Fueling Growth

The Smoking Epidemic and Esophageal Dysphagia

The surge in smoking rates is a significant contributor to the expanding esophageal dysphagia market. Smoking, a well-established risk factor for various health complications, can exacerbate esophageal dysphagia, leading to irritation and damage to the esophagus. Statistics from July 2022 revealed a 5.8% increase in cigarette production in Canada compared to the previous year, indicating a concerning upward trend in smoking habits. The treatment for esophageal dysphagia becomes crucial in mitigating health risks associated with smoking.

Market Players Responding to the Trend

Major players in the esophageal dysphagia market, including Nestle Health Science S.A., Novartis AG, and Abbott Laboratories, are at the forefront of addressing the challenges posed by rising smoking rates. Their focus on enhanced nutrition and hydration, reducing aspiration risk, and improving overall quality of life underscores the market’s commitment to combating the effects of smoking on esophageal health.

View More On The Esophageal Dysphagia Market Report 2023 – https://www.thebusinessresearchcompany.com/report/esophageal-dysphagia-global-market-report

Innovative Technologies Revolutionizing Treatment

Pharyngeal Electrical Stimulation (PES) Technology

In the pursuit of advancing esophageal dysphagia treatment, major companies are investing in cutting-edge technologies. Pharyngeal Electrical Stimulation (PES) technology has emerged as a game-changer in addressing swallowing disorders, particularly dysphagia resulting from neurological conditions. Companies like Phagenesis Ltd. are pioneering novel rehabilitation treatments, such as the Phagenyx neurostimulation system. This system utilizes intraluminal catheters introduced trans nasally to stimulate the pharynx directly, showcasing the potential of PES technology to enhance patients’ quality of life and reduce healthcare costs.

Market Expansion through Strategic Acquisitions

Patheous Health Inc.’s Strategic Move

In a significant development in May 2023, Patheous Health Inc., a key player in dysphagia care, acquired Carolina Speech Pathology LLC. This strategic move aims to broaden Patheous Health Inc.’s reach, enhance its service offerings, and tap into the talent pool of Carolina Speech Pathology LLC. This acquisition positions Patheous Health Inc. with a competitive edge in the dynamic dysphagia healthcare market, reflecting the growing trend of companies seeking expansion through strategic acquisitions.

Segmentation and Regional Outlook

Market Segmentation

The esophageal dysphagia market is segmented based on treatment, diagnosis, and end-user categories. Key treatment modalities include esophageal dilation, surgery, stent placement, laparoscopic Heller myotomy, medications, and lifestyle changes. The diagnostic landscape comprises dynamic swallowing studies, X-rays, endoscopes, manometry, imaging scans (MRI and CT scans). End-users span hospitals and clinics, ambulatory surgical centers, diagnostic centers, research centers, and other facilities.

Regional Dynamics

As of 2023, North America holds the largest share in the esophageal dysphagia market. Looking forward, the Asia-Pacific region is poised to be the fastest-growing market, highlighting the global nature of the esophageal dysphagia care landscape.

Request A Sample Of The Global Esophageal Dysphagia Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=13036&type=smp

The Esophageal Dysphagia Global Market Report 2023 provides an in-depth analysis on the esophageal dysphagia market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the esophageal dysphagia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –

Endoscopy Devices And Equipment Global Market Report 2023

Rigid Endoscope Global Market Report 2023

Endoscope Reprocessing Global Market Report 2023

Contact us at:
The Business Research Company:https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:

LinkedIn:https://in.linkedin.com/company/the-business-research-company

YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model